Pharmafile Logo

GMOs

- PMLiVE

EU takes legal steps against AZ over delayed COVID-19 vaccine deliveries

Lawyers for the European Commission have asked the court to fine AZ €10m per infraction

- PMLiVE

Sanofi, GSK begin enrolment for phase 3 COVID-19 vaccine study

Study will investigate two formulations targeting the Wuhan strain and the South African variant

- PMLiVE

Novartis, Molecular Partners launch global study of novel COVID-19 drug

Initial positive phase 1 study results found that the drug was safe and well tolerated, with no significant adverse events reported

- PMLiVE

Moderna’s COVID-19 vaccine offers high levels of protection for adolescents

The study results showed a vaccine efficacy of 100% starting 14 days after the second dose

- PMLiVE

The lessons learned from COVID-19’s impact on oncology trials

How COVID-19’s lasting legacy will reshape clinical cancer research

- PMLiVE

EMA concludes GSK, Vir’s mAb can be used to treat high-risk COVID-19 patients

Recommendations can be used to support national advice prior to marketing authorisation

- PMLiVE

AZ, Pfizer/BioNTech COVID-19 vaccines ‘highly effective’ against Indian variant

UK study finds vaccines are likely to be effective in preventing hospitalisation/death

- PMLiVE

Pfizer to evaluate its pneumococcal vaccine alongside COVID-19 booster jab

Trial will enrol 600 adults, aged 65 and older, from the phase 3 Pfizer/BioNTech COVID-19 vaccine trial

Improving Public Health Through Telemedicine

Laurence Girard, CEO of Fruit Street Health, shares his tips for aspiring HealthTech entrepreneurs, his views on the future of telemedicine and digital health, and why he thinks healthcare companies...

Impetus Digital

Social Media, Wearable Technologies, and AI

João Bocas, CEO, Keynote Speaker, Social Media Influencer & Advisor at Digital Salutem, shares his thoughts on several intriguing topics related to wearables, AI, machine learning, robotics, and other digital...

Impetus Digital

Advancing Human Health Through Precise Measures of Movement, Cognition, & Biometrics

Scott McMillan, CEO of XCO, discusses wearable technologies for chronic and acute disease monitoring, virtual trials, and assessment of athlete performance. Among other things, we also dive into the role...

Impetus Digital

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links